Faqtron

Image

Why was Remdesivir the first drug against COVID-19 to be recommended for EU authorisation?


Remdesivir was the first medicine against COVID-19 to be recommended for authorisation in the EU.

Source:


ASSERTION SUMMARY
Assertion Ratings
A 40%   B 40%   C 20%  D 0%   E 0%
(10 ratings)
Overall Quality
3/10
(10 ratings)
Overall Rateability
3/10
(10 ratings)
ASSERTION A

Remdesivir is vastly more profitable than hydroxychloroquine.

Hydroxychloroquine costs about 60 US cents per pill. Remdesivir costs about $1,000 per pill.

Veridity?
100%
(2 ratings)
Quality?
7/10
(2 ratings)
Rateability?
7/10
(2 ratings)
ASSERTION B

Assertion B

Veridity?
100%
(One rating)
Quality?
5/10
(One rating)
Rateability?
5/10
(One rating)
ASSERTION C

Assertion C

Veridity?
50%
(7 ratings)
Quality?
2/10
(7 ratings)
Rateability?
2/10
(7 ratings)

Comments